5:01 Acquisition Corp.

NasdaqCM:FVAM Stock Report

Market Cap: US$106.6m

5:01 Acquisition Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Andy Schwab

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.4yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO

Andy Schwab (51 yo)

2.4yrs

Tenure

Mr. Andrew J. Schwab, also known as Andy, B.S., serves as Director at Enliven Therapeutics, Inc. He serves as the Director for TMRW Life Sciences Holdings, LLC. He had been an Independent Director at Pear...

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Schwab
Co-CEO & Director2.4yrsno datano data
Kush Parmar
Co-CEO & Director2.4yrsno datano data
Rebecca Lucia
CFO & Treasurer2.3yrsno datano data
Galya Blachman
General Counsel & Secretary2.3yrsno datano data
Jason Ruth
Chief Business Officer2.3yrsno datano data

2.3yrs

Average Tenure

45yo

Average Age

Experienced Management: FVAM's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Schwab
Co-CEO & Director2.4yrsno datano data
Kush Parmar
Co-CEO & Director2.4yrsno datano data
Matthew Patterson
Independent Director2.3yrsUS$19.73k0.28%
$ 300.0k
Daniella Beckman
Independent Director2.3yrsUS$19.73k0.28%
$ 300.0k
Samantha Singer
Independent Director2.2yrsUS$6.25k0.28%
$ 300.0k

2.3yrs

Average Tenure

48yo

Average Age

Experienced Board: FVAM's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.